-+ 0.00%
-+ 0.00%
-+ 0.00%

DataMeds AI agrees to exchange 9.9% stakes with DiaGen AI

PUBT·11/18/2026 11:04:07
Diffusion vocale
DataMeds AI agrees to exchange 9.9% stakes with DiaGen AI
  • DataMeds AI will issue 630,000 common shares to DiaGen, representing 9.9% of its common shares outstanding on the agreement date.
  • In exchange, DiaGen will issue 9.9% of its fully diluted common shares outstanding to DataMeds.
  • The share exchange supports a cancer target discovery and drug development partnership between subsidiary Helomics and DiaGen.
  • The transaction's expected total value is $1.5 million in cash and in-kind contributions through project milestones.
  • DataMeds will cover up to 50% of compute expenses; DiaGen will fund wet-lab hard costs tied to milestones.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611180600ACCESSWRNAPR_____1253337) on November 18, 2026, and is solely responsible for the information contained therein.